Use of detergent to prevent initial responses to endotoxin in horses

American Journal of Veterinary Research

Volumn 57, Issue 7, 1996, Pages 1063-1066

  Longworth, Kim E ^a   Smith, Barbara L ^a   Staub, Norman C ^b   Steffey, Eugene P ^a   Serikov, Vladimir B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DETERGENT; ESCHERICHIA COLI ENDOTOXIN; SURFACTANT; TYLOXAPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; FEVER; HORSE; LEUKOPENIA; MALE; NONHUMAN; PULMONARY HYPERTENSION;

ANIMALS; BLOOD PRESSURE; BODY TEMPERATURE; DETERGENTS; ENDOTOXINS; ESCHERICHIA COLI; FEMALE; HORSES; INFUSIONS, INTRAVENOUS; LEUKOCYTE COUNT; MALE; PULMONARY ARTERY; PULMONARY CIRCULATION; TIME FACTORS;

EID: 0030017565     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. King JN, Gerring EL. Detection of endotoxin in cases of equine colic. Vet Rec 1988;123:269-271.
2. Morris DD. Endotoxemia in horses. J Vet Intern Med 1991; 5:167-181.
3. Moore JN, Morris DD. Endotoxemia and septicemia in horses: experimental and clinical correlates. J Am Vet Med Assoc 1992;200:1903-1914.
4. Tobias PS, Ulevitch RJ. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology 1993;187:227-232.
5. Ulevitch RJ. Recognition of bacterial endotoxins by receptors-dependent mechanisms. Adv Immunol 1993;53:267-289.
6. Morris DD, Crowe N, Moore JN. Correlation of clinical and laboratory data with serum tumor necrosis factor activity in horses with experimentally induced endotoxemia. Am J Vet Res 1990;51: 1935-1940.
7. Morris DD, Moore JN, Crowe N, et al. Effect of experimentally induced endotoxemia on serum interleukin-6 activity in horses. Am J Vet Res 1992;53:753-756.
8. 2(epoprostenol), and the hemodynamic changes in equine endotoxin shock. Am J Vet Res 1982;43:999-1002.
9. Carrick JB, Morris DD, Moore JN. Administration of a receptor antagonist for platelet-activating factor during equine endotoxemia. Equine Vet J 1993;25:152-157.
10. Hardie EM, Kruse-Elliott K. Endotoxic shock. Part I. Review of causes. J Vet Intern Med 1990;4:258-266.
11. Longworth KE, Jarvis KA, Tyler WS, et al. Pulmonary intravascular macrophages in horses and ponies. Am J Vet Res 1994; 55:382-388.
12. Warner AE, Brain JD. The cell biology and pathogenic role of pulmonary intravascular macrophages. Am J Physiol 1990;258:L1-L12.
13. Staub NC. Pulmonary vascular reactivity: a status report. In: Staub NC, ed. The pulmonary intravascular macrophage. Mount Kisco, NY: Futura, 1989;123-140.
14. Brigham KL, Bowers RE, Haynes J. Increased sheep lung vascular permeability caused by Escherichia coli endotoxin. Circ Res 1979;45:292-297.
15. Warner AE, DeCamp MM, Molina RM, et al. Pulmonary removal of circulating endotoxin results in acute lung injury in sheep. Lab Invest 1988;59:219-230.
16. Clark ES, Gantley B, Moore JN. Effects of slow infusion of a low dose of endotoxin on systemic haemodynamics in conscious horses. Equine Vet J 1991;23:18-21.
17. Kuida H, Gilbert RP, Hinshaw LB, et al. Species differences in effect of gram-negative endotoxin on circulation. Am J Physiol 1961;200:1197-1202.
18. Hales CA, Sonne L, Peterson M, et al. Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. J Clin Invest 1981;68:497-505.
19. Lindsey DC, Emerson TEJ, Thompson TE, et al. Characterization of an endotoxemic baboon model of metabolic and organ dysfunction. Circ Shock 1991;34:298-310.
20. Longworth KE, Westgate AM, Grady MK, et al. Development of pulmonary intravascular macrophage function in newborn lambs. J Appl Physiol 1992;73:2608-2615.
21. Atwood D, Florence AT. Surfactant systems: their chemistry, pharmacy and biology. New York: Chapman and Hall, 1983.
22. Morris MD, Zilversmit DB, Hintz HF. Hyperlipoproteinemia in fasting ponies. J Lipid Res 1972;13:383-389.
23. Sheorain VS, Rao TN, Subrahmanyam D. On the inhibition of lipoprotein lipase by Triton WR 1339. Enzyme 1980;25:81-86.
24. Nutting DF, Tso P. Hypolipidemic effect of intravenous Pluronic L-81 in fasted rats treated with Triton WR-1339: possible inhibition of hepatic lipoprotein secretion. Horm Metab Res 1989;21: 113-115.
25. Leighton F, Poole B, Beaufay H, et al. The large-scale separation of peroxisomes, mitochondria, and lysosomes from the livers of rats injected with Triton WR-1339. Improved isolation procedure, automated analysis, biochemical and morphological properties of fractions. J Cell Biol 1968;37:482-513.
26. Miller JB. Detergent aerosol therapy: a 15-year review of laboratory and clinical tolerance. Clin Med 1967;Oct:37-40.
27. DeAngelis RL, Findlay JWA. Metabolism of surfactants. Clin Perinatol 1993;20:697-710.
28. Miyamoto K, Schultz E, Heath T, et al. Pulmonary intravascular macrophages and hemodynamic effects of liposomes in sheep. J Appl Physiol 1988;64:1143-1152.
29. Wileman T, Harding C, Stahl P. Receptor mediated endocytosis. Biochem J 1985;232:1-14.
30. Sukow WW, Bailey J. Characterization of the binding of Triton X-100 to equine and rabbit serum albumin. Physiol Chem Phys 1981;13:455-459.
31. 3H]Triton WR-1339. Hoppe-Seyler's Z Physiol Chem 1971; 352:1347-1358.
32. D'Arcy Hart P, Gordon AH. Suggested role of lysosomal lipid in the contrasting effects of Triton WR-1339 and dextran on tuberculous infection. Nature 1969;222:672-673.
33. Moore JN, Garner HE, Shapland JE, et al. Lactic acidosis and arterial hypoxemia during sublethal endotoxemia in conscious ponies. Am J Vet Res 1980;41:1696-1698.